This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Institute of Technology. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovations of André Darveau
Introduction
André Darveau is a notable inventor based in St. Foy, Canada. He has made significant contributions to the field of genetics, particularly in the study of the Wilms' tumor gene. His work has implications for understanding kidney and gonadal tissue development and associated diseases.
Latest Patents
André Darveau holds a patent for the "Localization and characterization of the Wilms' tumor gene." This patent describes the Wilms' tumor gene associated with the 11p3 locus on the human chromosome. The gene encodes a transcription unit approximately 50 kb in size and an mRNA of approximately 3 kb, which is predominantly expressed in kidney and gonadal tissue. The gene undergoes alternative splicing, producing four very similar mRNA transcripts. The polypeptides encoded by the Wilms' tumor DNA include four 'zinc fingers' and a region rich in proline and glutamine, suggesting a role in transcription regulation.
Career Highlights
André Darveau is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in genetics and molecular biology. His work has garnered attention for its potential impact on cancer research and treatment.
Collaborations
He has collaborated with notable colleagues, including Katherine M Call and Thomas M Glaser, contributing to a rich environment of innovation and discovery.
Conclusion
André Darveau's contributions to the understanding of the Wilms' tumor gene highlight his role as an influential inventor in the field of genetics. His work continues to inspire advancements in medical research and treatment options.